10-gene biomarker at University of Miami's Sylvester Comprehensive Cancer Center predicts colon cancer patients' response to adjuvant chemotherapy.
10-gene biomarker identified at University of Miami's Sylvester Comprehensive Cancer Center may predict colon cancer patients' response to adjuvant chemotherapy, helping guide personalized treatment decisions. The study, led by Steven Chen, used tumor tissue samples from 109 stage II & III colon cancer patients to validate the biomarker's predictive power. Further clinical trials are needed before it can be used clinically.
July 26, 2024
3 Articles